Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs

Puntos clave

• Nanocarrier-mediated delivery enhances the effectiveness of CRISPR-Cas for targeting antibiotic-resistant superbugs.
• The system demonstrated a significant reduction of bacterial resistance, with up to 80% effectiveness in initial tests.
• Evaluation of the delivery method involved assessing gene-editing performance in various bacterial strains resistant to common antibiotics.
• This promising approach highlights the potential for CRISPR technology to address urgent challenges in antibiotic resistance.